ABSTRACT. Our previous report demonstrated that high concentration of taurine is present in rat milk for the first few days of lactation and plays an important role in the body growth of rat pups. In the present study, gene expression of rate-limiting enzyme for taurine biosynthesis, cysteine sulfinate decarboxylase (CSD) were examined in rat mammary gland. By RT-PCR, CSD mRNA was found to be expressed in rat mammary gland like that in the liver. The expression level of CSD mRNA in the mammary gland was higher in the earlier lactational stage (days 1 and 6 of lactation) than that in the later lactational stage (day 14). CSD mRNA expression in the mammary gland of non-pregnant rats was only a trace level. By in situ hybridization analysis, CSD mRNA was demonstrated in the epithelial cells of the mammary gland. These results suggest that high concentrations of taurine in the milk are at least partially resulted from de novo synthesis of taurine in mammary gland epithelial cells and that the expression pattern of CSD mRNA may be responsible for the changes in taurine levels in the milk during a lactational period.
It is well known that in many mammalian species a high concentration of taurine occurs in milk and that taurine is necessary for offspring during developmental stages [3, 11] . We have also recently shown that high concentrations of taurine, especially at the beginning of lactation, is mandatory for normal body growth of rat pups presumably by maintaining insulin-like growth factor-I (IGF-I) levels in the blood [5] . Taurine in milk is thought to be derived from the liver, because the milk taurine level was positively correlated with hepatic taurine concentration during a lactational period [15] . The hepatic taurine pool appears to increase just before parturition and rapidly decrease after the first few days of lactation when high levels of taurine are secreted into the milk [15] . However, the data in our previous study indicated that taurine concentrations in milk always highly exceeded those in dams' peripheral circulation, and administration of β-alanine, a transport antagonist of taurine, to lactating dams did not decrease taurine concentrations in the milk [5] . These observations make us hypothesize that taurine can be synthesized by the mammary gland, and that taurine synthesized in the mammary gland may be another important source of taurine in the milk.
While several possible pathways have been proposed for taurine synthesis, the most widely accepted pathway involves the oxidation of cysteine to cysteine sulphinic acid (CSA). CSA may be either decarboxylated, transaminated or oxidized. Decarboxylation of CSA by cysteine sulfinate decarboxylase (CSD) leads to hypotaurine, which can be further oxidized to taurine. Oxidation of CSA produces cysteic acid, which then may be decarboxylated by CSD to taurine. Thus, CSD is considered to be the main rate-limiting enzyme for taurine synthesis. The enzymatic activity of CSD was first identified in the liver [4] , and the CSD cDNA with approximately 1,800 bp length was generated from liver poly (A) + mRNA [6] . On the other hand, two CSD activities were separated in the brain by ion exchange chromatography and called CSDI and CSDII according to their elution order [9] . Their nature is now fully elucidated, and the previously called CSDII was shown to be an enzymatic activity expressed by glutamate decarboxylase (GAD), the biosynthetic enzyme of γ-aminobutyric acid (GABA) [9] . On the basis of kinetic, biochemical and immunochemical data [9, 12] , the previously called CSDI was demonstrated to be identical to the CSD found in the liver and is thus henceforth called simply CSD.
In the present study, to validate our hypothesis mentioned above, we investigated the expression of CSD mRNA in the mammary gland of lactating rats by means of RT-PCR and in situ hybridization.
MATERIALS AND METHODS
Experimental animals: Adult female Wistar-Imamichi rats (9-10 weeks old) were maintained under controlled conditions of light (12 hr of light, 12 hr of dark) and temperature (23 ± 1°C). They were given laboratory chow and water ad libitum throughout the study. Vaginal cytological examinations were conducted by daily sampling of vaginal smears, and only those rats showing consecutive regular 4-day cycles were used in this study. In the night of proestrous day, females were mated with males to provide pregnant and then lactating females. The day of parturition was designated as Day 1 of lactation. The non-pregnant female rats were used as the controls.
Extraction of total RNA from the mammary gland and liver: Animals were sacrificed by decapitation at Days 1, 6 and 14 of lactation. The mammary gland and liver were immediately dissected out and frozen in liquid nitrogen and stored at -80°C until RNA analysis. The mammary gland and liver of virgin females at approximately the same age were also removed similarly. Each fragment of the mammary gland and liver tissue was homogenized in guanidium thiocyanate homogenization buffer (4.0 M guanidium thiocyanate containing 0.1 M Tris-HCl pH 7.5 and 2% mercaptoethanol). After adding 250 µl of 10% sodium lauryl sarcosianate, the homogenate was centrifuged (15,000 × g for 10 min at room temperature) and the supernatant was added with 2 g CsCl. The samples were layered by using CsCl/EDTA solution (5.7 M CsCl, 0.1 M EDTA) in centrifuge tube, and then ultra-centrifuged at room temperature (about 20°C) for 24 hr at 21,000 × g. After ultra-centrifugation, the supernatant was remove and the pellet of RNA was washed with 70% ethanol and was dried at room temperature. The pellet of RNA was dissolve in the appropriate volume of water. The RNA was re-dissolved with appropriate water and was quantified by UV absorbance at 260 nm (1 OD=40 µg/ml). The total RNA samples were stored at -80°C until further analysis.
Procedure for RT-PCR: The primers were designed based on the sequence of rat CSD cDNA reported previously [6] . The forward primer, 5'-GATGGCTGACTCAAAACCAC-3' is from position 186-205 (20 bp), and the reverse primer, 5'-GTTAGAGATGGAACCACCAG-3' is from position 635-654 (20 bp). The predicted size of PCR product using these primers is 468 bp. As an internal control, rat β-actin gene was used to demonstrate equal loading. The forward and the reverse primers of β-actin were 5'-CGGAACCGCTCAT-TGCC-3' (17 bp) and 5'-ACCCACACTGTGCCCATCTA-3' (20 bp), respectively, and they amplified a 289 bp region of rat β-actin.
RT-PCR was carried out with a Gene Amp TM RNA PCR kit (PERKIN ELMER, NJ, U.S.A.). For the template to synthesize single stranded DNA, 1 µl of the total RNA was incubated at 42°C for 60 min, 99°C for 5 min and 5°C for 5 min in a final volume of 20 µl with 50 U cloned Moloney Murine Virus (M-MLV) Reverse Transcriptase and the following reagents: 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl 2 , 1 mM dNTP (1 mM each dATP, dCTP, dGTP and dTTP), 2.5 µM Random Hexamers primer and 1 U RNase Inhibitor. After the reaction, 5 µl of the RT mixture was added to 20 µl of the PCR solution (10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2 mM MgCl 2 , 31.25 mU AmpliTaq DNA polymerase) and CSD primers (50 pmol each). The mixture was overlaid with mineral oil (heavy white oil, Sigma, MO, U.S.A.). PCR incubation was operated with a thermal cycler (PERKIN ELMER, NJ, U.S.A.) for 33 or 35 cycles at 94°C for 1 min, 63°C for 1 min and 72°C for 1 min, and the final extension at 72°C for 10 min.
After PCR reaction, 5 µl of the reaction mixture was electrophoresed on a 1% agarose gel in 1xTAE buffer [13] and the bands were detected by ethydium bromide (2 µl/ml) staining. After washing with distilled water, the agarose gel was photographed by Kodak Polaroid film (Polaroid Polapan 667x).
Sequence analysis of PCR product: RT-PCR for the total RNA of the mammary gland from Day 1 of lactation was performed as mentioned above. A PCR product forming a band at approximately 468 bp was recovered, and after being cloned into the ligated pGEM ® -T vector (Promega Corp, WI, U.S.A.), it was transformed in E. coli JM109 competent cells, and the transformed cells were cloned and proliferated. The plasmid DNA was recovered from each transformants. The nucleotide sequence was determined with the dideoxy chain termination method using an Autoread Sequencing Kit and A.L.F. DNA sequencer (Pharmacia LKB, Uppsala, Sweden). The sequence was analyzed through GenBank database.
In situ hybridization: The mammary gland and liver removed from rats on Days 1 and 6 of lactation were fixed in 4% paraformaldehyde and embedded in paraffin. The tissues were sectioned (at 10 µm thickness) and mounted onto slides coated with 2% 3-aminopropyltriethoxysilane (Shin-etsu Kagaku, Tokyo, Japan).
The plasmid (pGEM ® -T) DNA containing 468 bp of rat liver CSD cDNA were linearized by NotI for antisense and DraII for sense. Digoxygenin (DIG)-labeled probes were transcribed from the linearized plasmids by using T7 (for antisense) or SP6 (for sense) RNA polymerase according to the manufacturer's specifications (Böhringer Mannheim GmbH, Mannheim, Germany). The DIG-labeled cRNA probes were denatured at 65°C for 10 min and diluted in hybridization buffer (50% formamide, 10 mM Tris-Cl pH 7.6, 600 mM NaCl, 1 mM EDTA, 0.25% SDS, 10% dextran sulfate, 200 µg/ml E. coli tRNA, 1xDenhardt's solution) to a final concentration of 1 µg cRNA/ml. After the sections were hybridized with DIG-labeled cRNA probes in a sealed container at 42°C for 16 hr, the sections were washed twice in 50% formamide, 2 × SSC at 42°C for 10 min. Slide sections were then treated with RNase (20 mg/ml/0.5 M NaCl, 10 mM Tris-Cl pH 8.0, 1 mM EDTA) at 37°C for 30 min. The sections were washed once in 2 × SSC, twice in 0.2 × SSC at 42°C for 20 min, respectively. Then the sections were placed in DIG-buffer 1 (100 mM Tris-Cl pH 7.5, 150 mM NaCl) at 4°C for overnight. The sections were placed in 1% blocking reagent (Böhringer Mannheim GmbH, Mannheim, Germany)/DIG-buffer 1 for 30 min the next day. The sections were treated with antiDigoxigenin-AP, Fab fragments (Böhringer Mannheim GmbH, Mannheim, Germany)/DIG-buffer 1 for 30 min. Finally the sections were treated with NBT/BCIP (Böhringer Mannheim GmbH, Mannheim, Germany)/DIG-buffer 3 (100 mM Tris-Cl pH 9.5, 100 mM NaCl, 50 mM MgCl 2 ) in a dark condition until the color development. After color development, sections were counter-stained with 0.3% methyl green.
RESULTS

Detection of CSD mRNA in rat mammary gland by RT-PCR:
RT-PCR was performed to determine whether CSD mRNA was expressed in the mammary gland as well as the liver. As Fig. 1 illustrates, PCR products at around the predicted size of 468 bp were obtained from the liver of Day 1, Day 6 and non-pregnant females. The bands at the same size were also amplified from the mammary gland samples of Day 1, Day 6 and non-pregnant females.
The nucleotide sequence of the PCR product from the mammary gland was analyzed and shown in Fig. 2 . The sequence had 99.8% homology with that of rat liver CSD cDNA that had been already reported [6] (only one nucleotide was different at position 537). From this result, we concluded that the mammary gland expressed the same molecular species as liver CSD mRNA.
Changes in CSD mRNA expression in the mammary gland during lactation: To analyze changes in the expression of CSD mRNA in the mammary gland during the lactational period, semi-quantitative RT-PCR was done utilizing total RNA extracted from the mammary gland of lactating rats on Days 1, 6 and 14 and non-pregnant rats as a template. As shown in Fig. 3 , the CSD mRNA expression in the mammary gland was much higher in earlier lactational stages (Days 1 and 6) than in a later stage (Day 14). The CSD mRNA expression in the mammary gland of non-pregnant rats was much lower than that of lactating rats.
Localization of CSD mRNA in the rat mammary gland: To determine which cell type is responsible for the expression of CSD mRNA in rat mammary gland, in situ localization was conducted on the mammary gland tissue obtained from lactating rats on Days 1 and 6. A positive reference was the liver tissue. As expected, the antisense probe produced strong signals in liver hepatocytes (Fig. 4) . The positive cells in the mammary gland were epithelial cells (Fig. 5) . Thus, the liver and mammary gland parenchyma was responsible for the expression of CSD mRNA.
DISCUSSION
Many previous works paid much attention to nutritional aspects of taurine, particularly in relationship to the development of neonates. For example, if the neonates of kittens could not ingest sufficient taurine from the milk, they would manifest variety of deficient diseases [18] . One of the reasons for this popularity is high concentrations of taurine in the milk of human and other mammals [11] . It has long been known that cats, humans and monkeys are dependent on dietary sources of taurine to maintain their body pools because they have only a limited capacity for taurine biosynthesis. Unlike these species, the rat has great capacity for taurine synthesis [7, 8, 16, 19] . The results in our previous study [5] , however, suggested that a high concentration of taurine in milk is essential for the normal body growth of rat pups. The question was whether the rat mammary gland per se could synthesize taurine as a source of taurine in the milk.
Despite considerable variations in the activity of CSD, the enzyme is considered to be primarily responsible for the synthesis of taurine among different species [8] . In rats, the liver is thought to be the major site of taurine biosynthesis [1, 2] . The synthesis of taurine has also been reported in the brain, lung and muscle tissue of the rat [1, 10, 14, 17] . Synthesis of taurine by these extra-hepatic tissues may be essential for their own tissues. In the present study, the expression of CSD mRNA was confirmed in the liver of both lactating and virgin females. We then detected, for the first time, the expression of CSD mRNA in the mammary gland by RT-PCR. The partial nucleotide sequence of the CSD cDNA in the mammary gland showed 99.8% homology with that in the liver. This made us conclude that the molecular species of CSD mRNA in rat mammary gland is the same as that in rat liver. We have previously shown that taurine concentration in rat milk is high for the first few days, and then gradually decreased to reach a plateau level during lactational period [5] . In the present study, the CSD mRNA expression in the mammary gland was higher in earlier stages than in the later stage of lactation. This change in CSD mRNA expression may be responsible for the profile of taurine concentration in the milk during a lactational period. It remains to be elucidated, however, what biological factors are involved in the regulation of the expression of CSD gene in the mammary gland during the lactational period. Perhaps changes in steroid environment during pregnancy and lactational period may be one of such factors.
The present study demonstrated that the mammary gland epithelial cells, as well as hepatocytes, was certainly the site for CSD mRNA expression. Although we have not yet conirmed the enzymatic activity of CSD in the mammary gland, the present results strongly suggest that rat mammary gland epithelial cells per se can synthesize at least a part of taurine to fulfill the demand for the growth of rat pups. This could explain our previous observations that taurine concentrations in the milk always markedly exceeded those in the serum of dams during the lactational period, and that intraperitoneal injection of β-alanine, a transport antagonist of taurine, to lactating dams did not affect taurine concentrations in the milk [5] . Thus, taurine synthesized in the rat mammary gland should be another source for milk taurine, as we presumed previously.
In conclusion, the present study demonstrated that the same molecular species of CSD mRNA as the liver is expressed in rat mammary gland epithelial cells and its pattern of expression may be at least partially responsible for the changes in taurine levels in the milk during a lactational period. 
